Literature DB >> 33089731

Genetic prion disease: opportunities for early therapeutic intervention with rigorous pre-symptomatic trials.

Peter Hermann1,2, Jan C Koch2, Inga Zerr1,2,3.   

Abstract

Entities:  

Year:  2020        PMID: 33089731     DOI: 10.1080/13543784.2020.1839048

Source DB:  PubMed          Journal:  Expert Opin Investig Drugs        ISSN: 1354-3784            Impact factor:   6.206


× No keyword cloud information.
  2 in total

Review 1.  The Use of Real-Time Quaking-Induced Conversion for the Diagnosis of Human Prion Diseases.

Authors:  Anna Poleggi; Simone Baiardi; Anna Ladogana; Piero Parchi
Journal:  Front Aging Neurosci       Date:  2022-04-25       Impact factor: 5.750

2.  Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases.

Authors:  Matthias Schmitz; Anna Villar-Piqué; Peter Hermann; Geòrgia Escaramís; Miguel Calero; Cao Chen; Niels Kruse; Maria Cramm; Ewa Golanska; Beata Sikorska; Pawel P Liberski; Maurizio Pocchiari; Peter Lange; Christiane Stehmann; Shannon Sarros; Eulàlia Martí; Inês Baldeiras; Isabel Santana; Dana Žáková; Eva Mitrová; Xiao-Ping Dong; Steven Collins; Anna Poleggi; Anna Ladogana; Brit Mollenhauer; Gabor G Kovacs; Michael D Geschwind; Raquel Sánchez-Valle; Inga Zerr; Franc Llorens
Journal:  Brain       Date:  2022-04-18       Impact factor: 15.255

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.